Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Sees Significant Growth in Short Interest

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 29,843 shares, an increase of 285.9% from the June 15th total of 7,733 shares. Currently, 3.3% of the shares of the company are short sold. Based on an average daily volume of 9,737 shares, the short-interest ratio is presently 3.1 days.

Virtus LifeSci Biotech Products ETF Stock Down 2.4%

Shares of BBP traded down $2.44 during midday trading on Monday, reaching $97.82. 13,960 shares of the stock were exchanged, compared to its average volume of 8,082. Virtus LifeSci Biotech Products ETF has a twelve month low of $60.91 and a twelve month high of $105.21. The stock’s 50 day simple moving average is $89.98 and its 200 day simple moving average is $85.28.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of BBP. Prime Capital Investment Advisors LLC acquired a new position in shares of Virtus LifeSci Biotech Products ETF in the 4th quarter valued at approximately $1,896,000. Comprehensive Financial Planning Inc. PA bought a new position in shares of Virtus LifeSci Biotech Products ETF in the 4th quarter valued at $557,000. Finally, Flow Traders U.S. LLC acquired a new position in Virtus LifeSci Biotech Products ETF in the 2nd quarter worth about $431,000.

Virtus LifeSci Biotech Products ETF Company Profile

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.